Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

October 09, 2018; 91 (15) Clinical/Scientific NotesOpen Access

Chorea, psychosis, acanthocytosis, and prolonged survival associated with ELAC2 mutations

Martin Paucar, Aleksandra Pajak, Christoph Freyer, Åsa Bergendal, Margit Döry, José Miguel Laffita-Mesa, Henrik Stranneheim, Kristina Lagerstedt-Robinson, Irina Savitcheva, Ruth H. Walker, Anna Wedell, Anna Wredenberg, Per Svenningsson
First published September 14, 2018, DOI: https://doi.org/10.1212/WNL.0000000000006320
Martin Paucar
From Karolinska University Hospital (M.P., A.P., C.F., M.D., J.L.-M., H.S., K.L., I.S., A. Wedell, A. Wredenberg, P.S.); Karolinska Institutet (M.P., A.P., C.F., Å.B., K.L., A. Wedell, A. Wredenberg, P.S.), Stockholm, Sweden; James J. Peters Veterans Medical Affair Center (R.H.W.), Bronx; and Mount Sinai School of Medicine (R.H.W.), New York, NY.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aleksandra Pajak
From Karolinska University Hospital (M.P., A.P., C.F., M.D., J.L.-M., H.S., K.L., I.S., A. Wedell, A. Wredenberg, P.S.); Karolinska Institutet (M.P., A.P., C.F., Å.B., K.L., A. Wedell, A. Wredenberg, P.S.), Stockholm, Sweden; James J. Peters Veterans Medical Affair Center (R.H.W.), Bronx; and Mount Sinai School of Medicine (R.H.W.), New York, NY.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christoph Freyer
From Karolinska University Hospital (M.P., A.P., C.F., M.D., J.L.-M., H.S., K.L., I.S., A. Wedell, A. Wredenberg, P.S.); Karolinska Institutet (M.P., A.P., C.F., Å.B., K.L., A. Wedell, A. Wredenberg, P.S.), Stockholm, Sweden; James J. Peters Veterans Medical Affair Center (R.H.W.), Bronx; and Mount Sinai School of Medicine (R.H.W.), New York, NY.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Åsa Bergendal
From Karolinska University Hospital (M.P., A.P., C.F., M.D., J.L.-M., H.S., K.L., I.S., A. Wedell, A. Wredenberg, P.S.); Karolinska Institutet (M.P., A.P., C.F., Å.B., K.L., A. Wedell, A. Wredenberg, P.S.), Stockholm, Sweden; James J. Peters Veterans Medical Affair Center (R.H.W.), Bronx; and Mount Sinai School of Medicine (R.H.W.), New York, NY.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Margit Döry
From Karolinska University Hospital (M.P., A.P., C.F., M.D., J.L.-M., H.S., K.L., I.S., A. Wedell, A. Wredenberg, P.S.); Karolinska Institutet (M.P., A.P., C.F., Å.B., K.L., A. Wedell, A. Wredenberg, P.S.), Stockholm, Sweden; James J. Peters Veterans Medical Affair Center (R.H.W.), Bronx; and Mount Sinai School of Medicine (R.H.W.), New York, NY.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
José Miguel Laffita-Mesa
From Karolinska University Hospital (M.P., A.P., C.F., M.D., J.L.-M., H.S., K.L., I.S., A. Wedell, A. Wredenberg, P.S.); Karolinska Institutet (M.P., A.P., C.F., Å.B., K.L., A. Wedell, A. Wredenberg, P.S.), Stockholm, Sweden; James J. Peters Veterans Medical Affair Center (R.H.W.), Bronx; and Mount Sinai School of Medicine (R.H.W.), New York, NY.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henrik Stranneheim
From Karolinska University Hospital (M.P., A.P., C.F., M.D., J.L.-M., H.S., K.L., I.S., A. Wedell, A. Wredenberg, P.S.); Karolinska Institutet (M.P., A.P., C.F., Å.B., K.L., A. Wedell, A. Wredenberg, P.S.), Stockholm, Sweden; James J. Peters Veterans Medical Affair Center (R.H.W.), Bronx; and Mount Sinai School of Medicine (R.H.W.), New York, NY.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kristina Lagerstedt-Robinson
From Karolinska University Hospital (M.P., A.P., C.F., M.D., J.L.-M., H.S., K.L., I.S., A. Wedell, A. Wredenberg, P.S.); Karolinska Institutet (M.P., A.P., C.F., Å.B., K.L., A. Wedell, A. Wredenberg, P.S.), Stockholm, Sweden; James J. Peters Veterans Medical Affair Center (R.H.W.), Bronx; and Mount Sinai School of Medicine (R.H.W.), New York, NY.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Irina Savitcheva
From Karolinska University Hospital (M.P., A.P., C.F., M.D., J.L.-M., H.S., K.L., I.S., A. Wedell, A. Wredenberg, P.S.); Karolinska Institutet (M.P., A.P., C.F., Å.B., K.L., A. Wedell, A. Wredenberg, P.S.), Stockholm, Sweden; James J. Peters Veterans Medical Affair Center (R.H.W.), Bronx; and Mount Sinai School of Medicine (R.H.W.), New York, NY.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ruth H. Walker
From Karolinska University Hospital (M.P., A.P., C.F., M.D., J.L.-M., H.S., K.L., I.S., A. Wedell, A. Wredenberg, P.S.); Karolinska Institutet (M.P., A.P., C.F., Å.B., K.L., A. Wedell, A. Wredenberg, P.S.), Stockholm, Sweden; James J. Peters Veterans Medical Affair Center (R.H.W.), Bronx; and Mount Sinai School of Medicine (R.H.W.), New York, NY.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Wedell
From Karolinska University Hospital (M.P., A.P., C.F., M.D., J.L.-M., H.S., K.L., I.S., A. Wedell, A. Wredenberg, P.S.); Karolinska Institutet (M.P., A.P., C.F., Å.B., K.L., A. Wedell, A. Wredenberg, P.S.), Stockholm, Sweden; James J. Peters Veterans Medical Affair Center (R.H.W.), Bronx; and Mount Sinai School of Medicine (R.H.W.), New York, NY.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Wredenberg
From Karolinska University Hospital (M.P., A.P., C.F., M.D., J.L.-M., H.S., K.L., I.S., A. Wedell, A. Wredenberg, P.S.); Karolinska Institutet (M.P., A.P., C.F., Å.B., K.L., A. Wedell, A. Wredenberg, P.S.), Stockholm, Sweden; James J. Peters Veterans Medical Affair Center (R.H.W.), Bronx; and Mount Sinai School of Medicine (R.H.W.), New York, NY.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Per Svenningsson
From Karolinska University Hospital (M.P., A.P., C.F., M.D., J.L.-M., H.S., K.L., I.S., A. Wedell, A. Wredenberg, P.S.); Karolinska Institutet (M.P., A.P., C.F., Å.B., K.L., A. Wedell, A. Wredenberg, P.S.), Stockholm, Sweden; James J. Peters Veterans Medical Affair Center (R.H.W.), Bronx; and Mount Sinai School of Medicine (R.H.W.), New York, NY.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Chorea, psychosis, acanthocytosis, and prolonged survival associated with ELAC2 mutations
Martin Paucar, Aleksandra Pajak, Christoph Freyer, Åsa Bergendal, Margit Döry, José Miguel Laffita-Mesa, Henrik Stranneheim, Kristina Lagerstedt-Robinson, Irina Savitcheva, Ruth H. Walker, Anna Wedell, Anna Wredenberg, Per Svenningsson
Neurology Oct 2018, 91 (15) 710-712; DOI: 10.1212/WNL.0000000000006320

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
668

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Biallelic mutations in the elaC ribonuclease Z 2 (ELAC2) gene cause a rare mitochondrial disease, the main features of which are hypertrophic cardiomyopathy, delayed psychomotor development, and usually death during childhood.1 Only 20 families have been reported with this syndrome.1,–,3 Neither movement disorders nor psychotic features have been described as part of the spectrum of ELAC2 mutations. We describe a patient with a complex hyperkinetic syndrome and acanthocytosis, harboring biallelic ELAC2 mutations.

Case description

An Assyrian 69-year-old woman born in Turkey was evaluated at our center for a slowly progressive Huntingtonian disorder. Family history was negative. The patient came to Sweden at age 33; she never went to school and learned only a few Swedish words, and could perform simple transactions. She had type 2 diabetes mellitus, bilateral sensorineural hearing loss requiring aids since age 58, and a follicular thyroid tumor, and is a silent carrier of α-thalassemia (table e-1; doi.org/10.5061/dryad.j6s420k).

At age 52 years, the patient developed short memory impairment and increasing difficulties managing activities of daily living. Four years later, she reported olfactory hallucinations and became obsessed with cleaning and doing laundry to remove the perceived foul smells. Perioral movements were documented during an emergency room visit at age 56 for psychiatric issues, and were noted by her family to have been present for many years, predating treatment with aripiprazole. The olfactory hallucinations became so severe that she tried to commit suicide by setting her apartment on fire at age 58. This resulted in admission to a psychiatric unit for a year and treatment with aripiprazole. At age 61, worsened gait, balance, and involuntary movements were evident. For the last 3 years, she has required a walker and reports numbness in her calves. She has lost weight, but there is no evidence of feeding dystonia or dysphagia. Recently, she has become fecally incontinent.

On examination, the patient had chorea in the feet and perioral area, dystonic posturing in the hands and reduced arm movements, a waddling gait, bradykinesia, apraxia, and atrophy of the hand muscles (video 1). A simplified psychometric evaluation demonstrated significant deficits in several domains (table e-2). EEG performed twice was normal; neurophysiologic studies revealed a sensorimotor demyelinating polyneuropathy and myopathy. Muscle biopsy revealed both cytochrome oxidase (COX)–negative and ragged-red fibers. Brain MRI demonstrated atrophy in the left perirolandic frontal and temporal cortex, while FDG-PET showed reduced bilateral hypometabolism in these regions and in the insular cortex, more pronounced on the left side (figures e-1 and e-2; doi.org/10.5061/dryad.j6s420k). An incidental aneurysm in the anterior communicating artery was found and treated conservatively; there was no evidence of brain calcifications on CT scans. Huntington disease (HD) and other HD phenocopies were ruled out (appendix; doi.org/10.5061/dryad.j6s420k). Acanthocytes were found on wet blood smears (figure e-3; doi.org/10.5061/dryad.j6s420k). Whole exome sequencing revealed compound heterozygous variants c.394G>A (p.Gly132Arg) and c.1040C>T (p.Ser347Phe) in the ELAC2 gene (figure e-4; doi.org/10.5061/dryad.j6s420k). ECG was normal but repeated echocardiography demonstrated stable mild ventricular septum hypertrophy without evidence of pump failure. Although we did not find any evidence of respiratory chain defect in the muscle biopsy, the patient's fibroblasts revealed accumulation of unprocessed mitochondrial transcripts but normal steady-state levels of mitochondrial mRNAs and tRNAs (figure 1, A and B). These fibroblasts showed severe growth impairment when using galactose as energy source (figure 1C). Treatment with coenzyme Q10 has been started and regular echocardiography is planned.

Video 1

The patient has mild chorea involving the lower face, trunk, and upper and lower limbs, which increases with activation. There is dystonic posturing of the fingers and arms, and a mild postural tremor of the right hand. There is bradykinesia and clumsiness of alternating movements of both upper and lower extremities, which has progressed between examinations (at ages 63 and 67 years). She has a waddling, wide-based, gait, which has progressed between the 2 recordings, and the right arm is held in an abducted, dystonic posture. Speech is mildly dysarthric.Download Supplementary Video 1 via http://dx.doi.org/10.1212/006320_Video_1

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure Northern blot analysis of total RNA extractions from primary fibroblasts

(A) Steady-state levels of mitochondrial mRNAs. 18S rRNA was used as loading control. Controls: C1 and C2, patient: ELAC2mut. (B) Steady-state levels of mitochondrial tRNA-tryptophane (mt-tW) and the nuclear-encoded tRNA-cysteine (cyto-tC) from control (C1, C2) and patient fibroblasts, grown for 14 days on galactose-containing medium. *Unprocessed mitochondrial transcript, arrow = tRNA. (C) Growth curves of control and patient fibroblasts grown on galactose. Experiments were performed in triplicates. Error bars indicate standard error.

Discussion

This case demonstrates that ELAC2 mutations are not exclusively confined to a lethal pediatric cardiomyopathy but can also be associated with symptoms and laboratory findings suggestive of a neuroacanthocytosis syndrome. Most patients with biallelic ELAC2 mutations reported to date have died during early infancy. In a Saudi cohort of 16 patients harboring the homozygous c.460T>C (p.Phe154Leu) mutation, the mean survival was 4 months.3 This dire prognosis makes the prolonged survival of our case remarkable. Apart from our patient, the oldest surviving patient is a 19-year-old patient with severe developmental delay and inability to walk.2 There was no dysmorphism or microcephaly, as have been reported with ELAC2 mutations.1,2 Accumulation of unprocessed mitochondrial transcripts and impaired fibroblast growth on galactose support pathogenicity for the ELAC2 variants we report. Other mitochondrial diseases associated with chorea include Leigh syndrome and mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS),4,5 although these are typically associated with basal ganglia lesions on imaging. Our patient had myopathy, hearing loss, diabetes, and polyneuropathy, which are typical of mitochondrial disease. Even though perioral chorea antedated treatment with aripiprazole, it is not possible to rule out that bradykinesia, dystonic hand posturing, and chorea in the trunk and feet may be side effects of this treatment. The radiologic abnormalities (unilateral frontal and temporal atrophy) and bilateral hypometabolism in the operculum and insula are also new findings for ELAC2 mutations. Interestingly, injuries in the insula have been reported in association with olfactory hallucinations.6

The presence of acanthocytosis, in addition to myopathy, polyneuropathy, and chorea, suggests a neuroacanthocytosis syndrome (i.e., chorea–acanthocytosis and McLeod syndrome, which were excluded in this case); dilated, but not hypertrophic, cardiomyopathy is typical in McLeod syndrome.7 One case of MELAS has been reported to be associated with acanthocytosis.8 We propose that ELAC2 should be added to the list of potential causes of neuroacanthocytosis syndromes.

Author contributions

M. Paucar, A. Wredenberg, R.H. Walker, K. Lagerstedt-Robinson, J. Laffita, A. Wedell, P. Svenningsson: study concept, data collection, writing of the manuscript. M. Paucar: wrote the first draft. A. Wedell, A. Wredenberg, C. Freyer, A. Pajak, H. Stranneheim, and K. Lagerstedt-Robinson: performed the assessment of mitochondrial function and genetic analysis. I. Savitcheva: contributed imaging data. Å. Bergendal: performed the cognitive evaluation. R.H. Walker, A. Wredenberg, A. Wedell, C. Freyer, Å. Bergendal, I. Savitcheva, J. Laffita, P. Svenningsson: editing of the manuscript.

Study funding

M. Paucar's research was supported by the Stockholm County Council. A. Wedell's research is supported by the Swedish Research Council (2016-01082), the Stockholm County Council (20170022), and the Knut & Alice Wallenberg Foundation (KAW 2013.0026 and KAW 2014.0293). A. Wredenberg is a Ragnar Söderberg Fellow in Medicine (M77/13); her research is supported by the Swedish Research Council AW (2016-02179), Stockholm County Council, and Knut & Alice Wallenberg Foundation. P. Svenningsson is a Wallenberg Clinical Scholar; his research is supported by the Stockholm County Council (ALF).

Disclosure

The authors report no disclosures relevant to the manuscript. Go to Neurology.org/N for full disclosures.

Publication history

Previously published at bioRxiv doi: 10.1101/244848. Received by Neurology: Neuroimmunology & Neuroinflammation February 8, 2018. Accepted in final form July 19, 2018.

Acknowledgment

The authors thank the patient and her son for participation; Dr. H. Salim for referring the patient; Dr. Inger Nennesmo for the neuropathologic investigation; and Nicole Lesko for assistance with the genetic data.

Footnotes

  • Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article. The Article Processing Charge was funded by the authors.

  • The Article Processing Charge was funded by Swedish Research Council.

  • Received February 8, 2018.
  • Accepted in final form July 19, 2018.
  • Copyright © 2018 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.

This is an open access article distributed under the terms of the Creative Commons Attribution License 4.0 (CC BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

References

  1. 1.↵
    1. Haack TB,
    2. Kopajtich R,
    3. Freisinger P, et al
    . ELAC2 mutations cause a mitochondrial RNA processing defect associated with hypertrophic cardiomyopathy. Am J Hum Genet 2013;93:211–223.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Akawi NA,
    2. Ben-Salem S,
    3. Hertecant J, et al
    . A homozygous splicing mutation in ELAC2 suggests phenotypic variability including intellectual disability with minimal cardiac involvement. Orphanet J Rare Dis 2016;11:139.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Shinwari ZMA,
    2. Almesned A,
    3. Alakhfash A, et al
    . The phenotype and outcome of infantile cardiomyopathy caused by a homozygous ELAC2 mutation. Cardiology 2017;137:188–192.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Singmaneesakulchai S,
    2. Limotai N,
    3. Jagota P,
    4. Bhidayasiri R
    . Expanding spectrum of abnormal movements in MELAS syndrome (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes). Mov Disord 2012;27:1495–1497.
    OpenUrlPubMed
  5. 5.↵
    1. Adam MP,
    2. Ardinger HH,
    3. Pagon RA, et al.
    1. Rahman S,
    2. Thorburn D
    . Nuclear gene-encoded Leigh syndrome overview. In: Adam MP, Ardinger HH, Pagon RA, et al., eds. GeneReviews® [Internet]. Seattle: University of Washington; 1993.
  6. 6.↵
    1. Beume LA,
    2. Klinger A,
    3. Reinhard M,
    4. Niesen WD
    . Olfactory hallucinations as primary symptom for ischemia in the right posterior insula. J Neurol Sci 2015;354:138–139.
    OpenUrl
  7. 7.↵
    1. Adam MP,
    2. Ardinger HH,
    3. Pagon RA, et al.
    1. Jung HH,
    2. Danek A,
    3. Walker RH,
    4. Frey BM,
    5. Gassner C
    . McLeod neuroacanthocytosis syndrome. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews®. Seattle: University of Washington; 1993.
  8. 8.↵
    1. Mukoyama M,
    2. Kazui H,
    3. Sunohara N,
    4. Yoshida M,
    5. Nonaka I,
    6. Satoyoshi E
    . Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes with acanthocytosis: a clinicopathological study of a unique case. J Neurol 1986;233:228–232.
    OpenUrlCrossRefPubMed

Letters: Rapid online correspondence

  • Reader response: Chorea, psychosis, acanthocytosis, and prolonged survival associated with ELAC2 mutations
    • Shakya Bhattacharjee, Neurologist, MRCP (UK), Specialist Registrar, Plymouth Hospital NHS Trust (UK)
    Submitted September 22, 2018
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Case description
    • Discussion
    • Author contributions
    • Study funding
    • Disclosure
    • Publication history
    • Acknowledgment
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study

Dr. Robert Shapiro and Dr. Amynah Pradhan

► Watch

Related Articles

  • No related articles found.

Topics Discussed

  • All Movement Disorders
  • All Genetics
  • Mitochondrial disorders
  • Chorea

Alert Me

  • Alert me when eletters are published
Neurology: 100 (5)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise